Skip to main content

Table 1 Characteristics of patients included in the immunohistochemistry study

From: Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease

Variable

AD patients (N=56)

Age at death (years)

 Median [IQR]

80.0 [72.0-87.0]

 Range

56.0, 96.0

Sex – n of patients (%)

 Female

37 (66.1)

 Male

19 (33.9)

Post mortem interval

 Median [IQR]

26.5 [19.0-34.0]

 Range

3.0, 96.0

 Missing (n)

4

Braak Stage – n of patients (%)

 IV

1 (1.8)

 V-VI

55 (98.2)

Thal – n of patients (%)

 2

2 (3.57)

 3

5 (8.93)

 4

16 (28.57)

 5

33 (58.93)